Who owns Urogen Pharma?
- Ticker: URGN
- CUSIP Number: m96088105
Tip: Access positions for across all investors
Analyze quarterly positions in Urogen Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Urogen Pharma stock
Who bought or sold Urogen Pharma this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Rtw Investments | 3.8M | $41M | 1% | Dec 2024 |
|
Adage Capital Partners GP | 2.9M | $31M | -22% | Dec 2024 |
|
BlackRock | 2.5M | $26M | -1% | Dec 2024 |
|
Menora Mivtachim Holdings | 2.3M | $25M | 0% | Dec 2024 |
|
Toronto-Dominion Bank | 1.7M | $19M | 100% | Dec 2024 |
|
Ubs Global Asset Management Americas | 1.4M | $15M | 3% | Dec 2024 |
|
Nantahala Capital Management | 1.4M | $15M | 100% | Dec 2024 |
|
Leucadia National Corporation | 966k | $10M | 0% | Dec 2024 |
|
UBS Group | 923k | $9.8M | 1916% | Dec 2024 |
|
Silverarc Capital Management | 901k | $11M | -18% | Sep 2024 |
|
Rosalind Advisors | 870k | $9.3M | 100% | Dec 2024 |
|
State Street Corporation | 808k | $8.6M | 5% | Dec 2024 |
|
Morgan Stanley | 767k | $8.2M | -65% | Dec 2024 |
|
Migdal Insurance & Financial Holdings | 687k | $7.3M | 0% | Dec 2024 |
|
Millennium Management | 646k | $6.9M | -57% | Dec 2024 |
|
Wildcat Capital Management | 496k | $5.3M | 0% | Dec 2024 |
|
DAFNA Capital Management | 493k | $5.2M | 7% | Dec 2024 |
|
Harel Insurance Investments & Financial Services | 463k | $4.9M | 0% | Dec 2024 |
|
Geode Capital Management | 462k | $4.9M | 1% | Dec 2024 |
|
Vestal Point Capital | 400k | $5.1M | 100% | Sep 2024 |
|
T. Rowe Price Associates | 394k | $4.2M | 2969% | Dec 2024 |
|
Parkman Healthcare Partners | 370k | $3.9M | 6% | Dec 2024 |
|
Stonepine Capital Management | 324k | $3.5M | 16% | Dec 2024 |
|
Goldman Sachs Group | 318k | $3.4M | 0% | Dec 2024 |
|
Point72 Asset Management | 317k | $3.4M | -79% | Dec 2024 |
|
Northern Trust | 310k | $3.3M | 8% | Dec 2024 |
|
Woodline Partners | 306k | $3.3M | 0% | Dec 2024 |
|
Cormorant Asset Management | 300k | $3.2M | -81% | Dec 2024 |
|
Vanguard Group | 297k | $3.2M | 5% | Dec 2024 |
|
Citadel Advisors | 296k | $3.2M | -2% | Dec 2024 |
|
Rice Hall James & Associates | 264k | $2.8M | -3% | Dec 2024 |
|
Stempoint Capital | 242k | $3.1M | 100% | Sep 2024 |
|
Hudson Bay Capital Management | 233k | $2.5M | 100% | Dec 2024 |
|
Wells Fargo & Company | 222k | $2.4M | 3% | Dec 2024 |
|
Opaleye Management | 220k | $2.3M | -46% | Dec 2024 |
|
Alliancebernstein | 199k | $2.1M | 752% | Dec 2024 |
|
Dr. Jeffrey R. Jay, M.D. | 188k | $2.0M | -75% | Dec 2024 |
|
Trexquant Investment | 173k | $1.8M | -36% | Dec 2024 |
|
Wellington Management Company | 147k | $1.6M | 7% | Dec 2024 |
|
Atom Investors | 146k | $1.6M | 100% | Dec 2024 |
|
ARK Investment Management | 140k | $1.5M | 15% | Dec 2024 |
|
Renaissance Technologies | 138k | $1.5M | 100% | Dec 2024 |
|
Marshall Wace | 137k | $1.5M | 100% | Dec 2024 |
|
Epoch Investment Partners | 126k | $1.3M | -8% | Dec 2024 |
|
Bank of New York Mellon | 94k | $1.0M | 7% | Dec 2024 |
|
Charles Schwab Investment Management | 94k | $996k | 3% | Dec 2024 |
|
Nuveen Asset Management | 93k | $990k | -38% | Dec 2024 |
|
De Lisle Partners | 82k | $1.0M | 0% | Sep 2024 |
|
Annandale Capital | 76k | $805k | 0% | Dec 2024 |
|
Wesbanco Trust And Investments | 74k | $792k | 0% | Dec 2024 |
|
Bank of America Corporation | 73k | $772k | 9% | Dec 2024 |
|
Barclays | 69k | $738k | 16% | Dec 2024 |
|
Schonfeld Strategic Advisors | 68k | $725k | -45% | Dec 2024 |
|
Oak Ridge Investments | 61k | $651k | -20% | Dec 2024 |
|
Two Sigma Investments | 57k | $606k | -35% | Dec 2024 |
|
Swiss National Bank | 57k | $603k | 0% | Dec 2024 |
|
TD Asset Management | 53k | $569k | 100% | Dec 2024 |
|
Rhumbline Advisers | 51k | $546k | 3% | Dec 2024 |
|
Squarepoint Ops | 50k | $535k | -53% | Dec 2024 |
|
Ameriprise Financial | 49k | $524k | 9% | Dec 2024 |
|
Susquehanna International | 40k | $427k | -57% | Dec 2024 |
|
LLBH Private Wealth Management | 39k | $415k | -4% | Dec 2024 |
|
Citigroup | 38k | $405k | 35% | Dec 2024 |
|
Manufacturers Life Insurance Company | 38k | $399k | 178% | Dec 2024 |
|
Meitav Dash Investments | 36k | $385k | 0% | Dec 2024 |
|
Robert Bender & Associates | 35k | $370k | 100% | Dec 2024 |
|
ALPS Advisors | 34k | $363k | 0% | Dec 2024 |
|
ExodusPoint Capital Management | 34k | $358k | 100% | Dec 2024 |
|
Kovitz Investment Group Partners | 31k | $333k | 0% | Dec 2024 |
|
Deutsche Bank Aktiengesellschaft | 31k | $333k | 62% | Dec 2024 |
|
Toroso Investments | 31k | $325k | -19% | Dec 2024 |
|
Verition Fund Management | 29k | $305k | 116% | Dec 2024 |
|
Sherbrooke Park Advisers | 28k | $361k | 100% | Sep 2024 |
|
California State Teachers Retirement System | 28k | $300k | 1% | Dec 2024 |
|
Jane Street | 26k | $281k | -14% | Dec 2024 |
|
AQR Capital Management | 26k | $272k | -78% | Dec 2024 |
|
Palo Alto Investors | 25k | $261k | 0% | Dec 2024 |
|
Balyasny Asset Management | 25k | $261k | -14% | Dec 2024 |
|
Main Street Financial Solutions | 24k | $256k | 0% | Dec 2024 |
|
MetLife Investment Advisors | 23k | $243k | 14% | Dec 2024 |
|
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet | 22k | $232k | 0% | Dec 2024 |
|
Jpmorgan Chase & Co | 21k | $225k | -69% | Dec 2024 |
|
Mirae Asset Global Etfs Holdings | 21k | $263k | 41% | Sep 2024 |
|
SG Americas Securities | 20k | $216k | 44% | Dec 2024 |
|
Vivaldi Capital Management | 20k | $211k | 0% | Dec 2024 |
|
FMR | 20k | $213k | -14% | Dec 2024 |
|
Legal & General Group | 20k | $211k | 25% | Dec 2024 |
|
Susquehanna Fundamental Investments | 20k | $208k | 100% | Dec 2024 |
|
Corebridge Financial | 19k | $205k | 100% | Dec 2024 |
|
XTX Topco | 19k | $199k | -20% | Dec 2024 |
|
Engineers Gate Manager | 18k | $193k | -10% | Dec 2024 |
|
Jump Financial | 17k | $183k | -70% | Dec 2024 |
|
Cresset Asset Management | 17k | $178k | 0% | Dec 2024 |
|
Corton Capital | 16k | $199k | 100% | Sep 2024 |
|
Henderson Group | 14k | $149k | 100% | Dec 2024 |
|
Invesco | 14k | $143k | 5% | Dec 2024 |
|
ProShare Advisors | 13k | $137k | 100% | Dec 2024 |
|
Pale Fire Capital SE | 13k | $133k | 100% | Dec 2024 |
|
Intech Investment Management | 12k | $155k | 100% | Sep 2024 |
|
Zurcher Kantonalbank | 12k | $127k | 100% | Dec 2024 |
|
Oppenheimer & Co | 12k | $127k | 100% | Dec 2024 |
|
Ing Investment Management | 11k | $120k | -4% | Dec 2024 |
|
Shikiar Asset Management | 11k | $114k | 0% | Dec 2024 |
|
Ethos Financial Group | 11k | $112k | 0% | Dec 2024 |
|
China Universal Asset Management | 8.9k | $95k | 10% | Dec 2024 |
|
New York State Common Retirement Fund | 7.8k | $83k | 0% | Dec 2024 |
|
Lazard Asset Management | 6.4k | $67k | 100% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 4.8k | $51k | -44% | Dec 2024 |
|
Summit Investment Advisors | 3.8k | $41k | 0% | Dec 2024 |
|
Royal Bank of Canada | 3.7k | $41k | -39% | Dec 2024 |
|
Advisor Group Holdings | 1.7k | $19k | 173% | Dec 2024 |
|
Tower Research Capital | 1.6k | $17k | -11% | Dec 2024 |
|
Mirae Asset Global Investments | 1.4k | $15k | -8% | Dec 2024 |
|
Group One Trading | 1.4k | $15k | -82% | Dec 2024 |
|
Activest Wealth Management | 1.0k | $11k | 0% | Dec 2024 |
|
Amalgamated Bank | 943.00 | $10k | 0% | Dec 2024 |
|
Gf Fund Management | 886.00 | $9.4k | 100% | Dec 2024 |
|
Atlantic Trust | 509.00 | $5.6k | 0% | Dec 2024 |
|
Sterling Capital Management | 317.00 | $3.4k | 510% | Dec 2024 |
|
True Wealth Design | 161.00 | $2.0k | 100% | Sep 2024 |
|
Daiwa Securities Group | 160.00 | $2.0k | 0% | Dec 2024 |
|
GAMMA Investing | 107.00 | $1.1k | 32% | Dec 2024 |
|
CWM | 85.00 | $999.999500 | -95% | Dec 2024 |
|
SBI Securities | 67.00 | $713.998900 | 100% | Dec 2024 |
|
Us Bancorp | 47.00 | $501.001200 | 0% | Dec 2024 |
|
NISA Investment Advisors | 30.00 | $320.001000 | -82% | Dec 2024 |
|
Rothschild Investment | 30.00 | $381.000000 | 100% | Sep 2024 |
|
Quadrant Capital | 26.00 | $276.998800 | 0% | Dec 2024 |
|
Signature | 22.00 | $234.000800 | -94% | Dec 2024 |
|
Farther Finance Advisors | 12.00 | $128.000400 | 0% | Dec 2024 |
|
EverSource Wealth Advisors | 8.00 | $85.000000 | 100% | Dec 2024 |
|
IFP Advisors | 4.00 | $43.000000 | 100% | Dec 2024 |
|
Who sold out of Urogen Pharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Cowen And Company | Sep 2024 | 1.8M | $23M |
AWM Investment Company | Sep 2024 | 140k | $1.8M |
Monashee Investment Management | Sep 2024 | 55k | $699k |
HighVista Strategies | Sep 2024 | 39k | $490k |
Two Sigma Advisers | Sep 2024 | 25k | $311k |
GSA Capital Partners | Sep 2024 | 20k | $249k |
Simplex Trading | Sep 2024 | 19k | $241k |
Prudential Financial | Sep 2024 | 17k | $216k |
Partners Capital Investment Group | Sep 2024 | 15k | $195k |
Bayesian Capital Management | Sep 2024 | 14k | $178k |
Cubist Systematic Strategies | Sep 2024 | 13k | $170k |
Nbc Securities | Sep 2024 | 647.00 | $8.0k |
Pnc Financial Services | Sep 2024 | 500.00 | $6.4k |
Russell Investments | Sep 2024 | 253.00 | $3.2k |
Capital Performance Advisors | Sep 2024 | 138.00 | $1.8k |
Bessemer | Sep 2024 | 85.00 | $999.999500 |
SRS Capital Advisors | Sep 2024 | 56.00 | $712.000800 |